Home
Kate Ellingson is an epidemiologist at the Centers for Disease Control and Prevention (CDC) in the Division of Healthcare Quality Promotion (DHQP). She began her CDC career in 2006 in the Epidemic Intelligence Service, where she spent two years with DHQP investigating the transmission of infectious pathogens in healthcare settings and evaluating prevention initiatives designed to reduce such infections. She has worked on several projects specific to Methicillin-Resistant Staphylococcus aureus (MRSA), including an evaluation of an initiative to reduce MRSA transmission in VA hospitals, an assessment of antimicrobial resistance on the US-Mexico border, and a policy analysis of a state mandate for public reporting of hospital-associated MRSA infections. Dr. Ellingson has worked internationally in Kenya and Uganda to build infection control capacity and reduce amplification of outbreaks in East African hospitals. She has also led domestic investigations into quality of care for dialysis patients and for transfusion and transplant recipients. Her current position emphasizes quantitative statistical analysis and the translation of CDC-guidelines into feasible practices.